Orexigen Signs Obesity-Drug Pact With Takeda - Wall Street Journal

[INCIID News Feed]

RTT News
<img alt="" height="1" width="1" />
Orexigen Signs Obesity-Drug Pact With Takeda
Wall Street Journal
NEW YORK—Orexigen Therapeutics Inc. signed a North American partnership for its experimental obesity drug Contrave with Takeda Pharmaceutical Co. for $50 million and the potential for later payments that could exceed $1 billion. ...
Orexigen, Takeda in deal worth $1 bln for obesity drugReuters
Orexigen Shares Climb Most in More Than Year as Takeda Licenses Diet PillBloomberg
Orexigen signs licensing deal for obesity drugBusinessWeek
MarketWatch -TheStreet.com -Genetic Engineering News
all 47 news articles &raquo;


More...